Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-04-23
1982-08-03
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
546152, 546334, 546340, 546275, 548214, 548240, 424258, C07D41304, A61K 3144
Patent
active
043427715
ABSTRACT:
Hypoglycemic 5-chromanyl, 2,3-dihydro-5-benzo[b]furanyl, 5-pyridyl, 5-quinolyl, 5-pyrrolyl, 5-indolyl, 5-thiazolyl, 5-oxazolyl, 5-isothiazolyl and 5-isoxazolyl oxazolidine-2,4-diones and the pharmaceutically acceptable salts thereof; certain 3-acylated derivatives thereof; a method of treating hyperglycemic animals therewith; and intermediates useful in the preparation of said compounds.
REFERENCES:
patent: 2338220 (1944-01-01), Wallingford
patent: 2721197 (1955-08-01), Sheehan
patent: 3699229 (1972-10-01), Plotnikoff
patent: 4220787 (1980-09-01), Scholz
Ciamacian and Silber, Ber. 19, pp. 1708-1714 (1886).
Clark-Lewis, Chem. Rev. 58, pp. 63-99 (1958).
Brink and Freeman, J. Neuro. Chem. 19 (7), pp. 1783-1788 (1972).
Blackwood Robert K.
Frost Albert E.
Knuth Charles J.
Pfizer Inc.
Rotman Alan L.
LandOfFree
Hypoglycemic 5-substituted oxazolidine-2,4-diones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoglycemic 5-substituted oxazolidine-2,4-diones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycemic 5-substituted oxazolidine-2,4-diones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1468430